NCT02987946 - Leiden Trial in Prevention of Post-Operative ThromboEmbolic Events | Biotech Hunter

Enrollment

280

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2023

Study Completion Date

September 30, 2024

Conditions

Deep-Venous Thrombosis

Interventions

DEVICE

IPD Device delivered by Converis

After randomization patients will be subjected to perioperative (48 hrs) intermittent pneumatic compression.

DRUG

Fraxiparine

All patients receive Fraxiparine 2850 IE daily, starting preoperatively compatible with current practice.

Trial Locations (1)

Leiden University Medical Centre, Leiden